Hot topics in postsmall bowel transplantation: Noninvasive graft monitoring including stool calprotectin and plasma citrulline

Current Opinion in Organ Transplantation

Volumn 16, Issue 3, 2011, Pages 316-322

  Mercer, David F ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

noninvasive monitoring; rejection; small intestine transplantation

Indexed keywords

BILE ACID; CALGRANULIN; CITRULLINE; GENTAMICIN; GRANZYME B; PERFORIN;

AMINO ACID BLOOD LEVEL; ARTICLE; BIOPSY TECHNIQUE; EARLY DIAGNOSIS; FECES ANALYSIS; GRAFT REJECTION; HISTOPATHOLOGY; HUMAN; INTESTINE TRANSPLANTATION; LASER DOPPLER FLOWMETRY; NON INVASIVE PROCEDURE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PREDICTIVE VALUE;

EID: 85027955730     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e3283467115     Document Type: Article

References (23)

1. Abu-Elmagd KM, Costa G, Bond GJ, et al. Five hundred intestinal and multivisceral transplantations at a single center: major advances with new challenges. Ann Surg 2009; 250:567-581.
2. Miyagi K, Kiyochi H, Honda K, et al. Changes in the composition of serum bile acid as a predictor of small bowel allograft rejection in rats. Transplantation 2001; 71:565-569. (Pubitemid 32207209)
3. Yandza T, Gerhardt MF, Saint-Paul MC, et al. Significance of serum bile acids in small bowel allograft rejection in pigs. Transplantation 2009; 87:24-28.
4. Oltean M, Herlenius G, Dindelegan G, et al. Laser-Doppler flowmetry in the monitoring of the human intestinal allograft: a preliminary report. Transplant Proc 2006; 38:1723-1725. (Pubitemid 44190008)
5. Haghighi KS, Sharif K, Gupte G, et al. Is serum gentamicin level a good predictor of graft injury in intestinal transplantation? Transplant Proc 2006; 38:1733-1734. (Pubitemid 44190064)
6. Corti B, Altimari A, Gabusi E, et al. Potential of real-time PCR assessment of granzyme B and perforin up-regulation for rejection monitoring in intestinal transplant recipients. Transplant Proc 2005; 37:4467-4471. (Pubitemid 43016058)
7. Corti B, Altimari A, Gabusi E, et al. Two years' experience of acute rejection monitoring of intestinal transplant recipients by real-time PCR assessment of granzyme B and perforin up-regulation: considerations on diagnostic accuracy. Transplant Proc 2006; 38:1726-1727. (Pubitemid 44190019)
8. D'Errico A, Corti B, Pinna AD, et al. Granzyme B and perforin as predictive markers for acute rejection in human intestinal transplantation. Transplant Proc 2003; 35:3061-3065. (Pubitemid 38102132)
9. Altimari A, Gruppioni E, Capizzi E, et al. Blood monitoring of granzyme B and perforin expression after intestinal transplantation: considerations on clinical relevance. Transplantation 2008; 85:1778-1783.
10. Pappas PA, Saudubray JM, Tzakis AG, et al. Serum citrulline and rejection in small bowel transplantation: a preliminary report. Transplantation 2001; 72:1212-1216. (Pubitemid 33026597)
11. Curis E, Crenn P, Cynober L. Citrulline and the gut. Curr Opin Clin NutrMetab Care 2007; 10:620-626. (Pubitemid 47254725)
12. Crenn P, Coudray-Lucas C, Thuillier F, et al. Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans. Gastroenterology 2000; 119:1496-1505. (Pubitemid 32198675)
13. Gondolesi G, Fishbein T, Chehade M, et al. Serum citrulline is a potential marker for rejection of intestinal allografts. Transplant Proc 2002; 34:918-920. (Pubitemid 34556858)
14. Gondolesi GE, Kaufman SS, Sansaricq C, et al. Defining normal plasma citrulline in intestinal transplant recipients. Am J Transplant 2004; 4:414-418. (Pubitemid 38282298)
15. Gondolesi G, Ghirardo S, Raymond K, et al. The value of plasma citrulline to predict mucosal injury in intestinal allografts. Am J Transplant 2006; 6:2786-2790. (Pubitemid 44571701)
16. Pappas PA, Tzakis G, Gaynor JJ, et al. An analysis of the association between serum citrulline and acute rejection among 26 recipients of intestinal transplant. Am J Transplant 2004; 4:1124-1132. (Pubitemid 38868604)
17. David AI, Selvaggi G, Ruiz P, et al. Blood citrulline level is an exclusionary marker for significant acute rejection after intestinal transplantation. Transplantation 2007; 84:1077-1081. (Pubitemid 350125347)
18. Ruiz P, Tryphonopoulos P, Island E, et al. Citrulline evaluation in bowel transplantation. Transplant Proc 2010; 42:54-56.
19. Donato R. Intracellular and extracellular roles of S100 proteins. Microsc Res Tech 2003; 60:540-551.
20. Konikoff MR, Denson LA. Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease. Inflamm Bowel Dis 2006; 12:524-534.
21. Sudan D, Vargas L, Sun Y, et al. Calprotectin: A novel noninvasive marker for intestinal allograft monitoring. Ann Surg 2007; 246:311-315. (Pubitemid 47196530)
22. Akpinar E, Vargas J, Kato T, et al. Fecal calprotectin level measurements in small bowel allograft monitoring: a pilot study. Transplantation 2008; 85:1281-1286. (Pubitemid 351670477)
23. Cagnola H, Scaravonati R, Cabanne A, et al. Evaluation of calprotectin level in intestinal content as an early marker for graft rejection. Transplant Proc 2010; 42:57-61.